Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) – Leerink Partnrs increased their FY2025 earnings per share estimates for Inspire Medical Systems in a research report issued on Wednesday, November 8th. Leerink Partnrs analyst M. Kratky now expects that the company will post earnings per share of $0.58 for the year, up from their prior estimate of $0.57. Leerink Partnrs has a “Market Perform” rating on the stock. The consensus estimate for Inspire Medical Systems’ current full-year earnings is ($1.64) per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ FY2027 earnings at $4.09 EPS.
Other research analysts have also issued reports about the company. Mizuho lowered their target price on Inspire Medical Systems from $300.00 to $215.00 and set a “buy” rating on the stock in a report on Wednesday. TheStreet lowered Inspire Medical Systems from a “c-” rating to a “d+” rating in a report on Thursday, October 26th. JPMorgan Chase & Co. lowered their target price on Inspire Medical Systems from $340.00 to $181.00 and set an “overweight” rating on the stock in a report on Tuesday, October 17th. Stifel Nicolaus lowered their target price on Inspire Medical Systems from $350.00 to $250.00 and set a “buy” rating on the stock in a report on Tuesday, November 7th. Finally, Piper Sandler lifted their target price on Inspire Medical Systems from $340.00 to $360.00 in a report on Tuesday, July 18th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $283.92.
Inspire Medical Systems Stock Down 0.9 %
Shares of NYSE INSP opened at $125.70 on Friday. Inspire Medical Systems has a fifty-two week low of $124.03 and a fifty-two week high of $330.00. The firm’s 50-day simple moving average is $179.59 and its 200 day simple moving average is $248.40. The stock has a market cap of $3.71 billion, a P/E ratio of -111.24 and a beta of 1.48.
Inspire Medical Systems (NYSE:INSP – Get Free Report) last issued its quarterly earnings data on Tuesday, November 7th. The company reported ($0.29) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.53) by $0.24. Inspire Medical Systems had a negative net margin of 5.75% and a negative return on equity of 6.32%. The business had revenue of $153.30 million for the quarter, compared to analysts’ expectations of $154.49 million. During the same period in the previous year, the business earned ($0.60) earnings per share. The company’s revenue was up 40.4% on a year-over-year basis.
Institutional Investors Weigh In On Inspire Medical Systems
Several large investors have recently made changes to their positions in the company. Commonwealth Equity Services LLC grew its stake in shares of Inspire Medical Systems by 0.5% in the 1st quarter. Commonwealth Equity Services LLC now owns 6,774 shares of the company’s stock valued at $1,585,000 after buying an additional 36 shares in the last quarter. Metropolitan Life Insurance Co NY grew its stake in shares of Inspire Medical Systems by 2.3% in the 4th quarter. Metropolitan Life Insurance Co NY now owns 1,734 shares of the company’s stock valued at $437,000 after buying an additional 39 shares in the last quarter. Ameritas Investment Partners Inc. grew its stake in shares of Inspire Medical Systems by 1.9% in the 1st quarter. Ameritas Investment Partners Inc. now owns 2,255 shares of the company’s stock valued at $528,000 after buying an additional 42 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its position in Inspire Medical Systems by 3.9% during the second quarter. Mercer Global Advisors Inc. ADV now owns 1,122 shares of the company’s stock worth $364,000 after purchasing an additional 42 shares during the period. Finally, Y Intercept Hong Kong Ltd boosted its position in Inspire Medical Systems by 3.7% during the second quarter. Y Intercept Hong Kong Ltd now owns 1,200 shares of the company’s stock worth $390,000 after purchasing an additional 43 shares during the period. Institutional investors own 94.91% of the company’s stock.
About Inspire Medical Systems
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
- Five stocks we like better than Inspire Medical Systems
- Energy and Oil Stocks Explained
- MarketBeat Week in Review – 11/6 – 11/10
- Dividend Tax Calculator
- Data giants MongoDB and Snowflake just got upgraded
- Your Comprehensive Guide to Investing in Bank Stocks
- Plug Power at tipping point; it’s make or break time for hydrogen
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.